Literature DB >> 10997770

Evolution and treatment of migraine with oral contraceptives.

H Massiou1, E A MacGregor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10997770     DOI： 10.1046/j.1468-2982.2000.00038.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  17 in total

Review 1.  Hormonal contraception and migraine: clinical considerations.

Authors:  Stephanie S Faubion; Petra M Casey; Lynne T Shuster
Journal:  Curr Pain Headache Rep       Date:  2012-10

Review 2.  Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Authors:  Peer Tfelt-Hansen; Frederik Nybye Ågesen; Agniezka Pavbro; Jacob Tfelt-Hansen
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

3.  Hormonal manipulation strategies in the management of menstrual migraine and other hormonally related headaches.

Authors:  Lynne T Shuster; Stephanie S Faubion; Richa Sood; Petra M Casey
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 4.  [Non-alimentary trigger factors of migraine and tension-type headache].

Authors:  J Holzhammer; C Wöber
Journal:  Schmerz       Date:  2006-06       Impact factor: 1.107

5.  Oral contraceptives in migraine therapy.

Authors:  Gianni Allais; Ilaria Castagnoli Gabellari; Cristina De Lorenzo; Ornella Mana; Chiara Benedetto
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

6.  Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine.

Authors:  Raffaele Palmirotta; Piero Barbanti; Cristiano Ialongo; Maria Laura De Marchis; Jhessica Alessandroni; Gabriella Egeo; Cinzia Aurilia; Luisa Fofi; Maria Giovanna Valente; Patrizia Ferroni; David Della-Morte; Fiorella Guadagni
Journal:  DNA Cell Biol       Date:  2014-12-10       Impact factor: 3.311

Review 7.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

8.  The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups.

Authors:  Natalie J Colson; Rod A Lea; Sharon Quinlan; John MacMillan; Lyn R Griffiths
Journal:  Neurogenetics       Date:  2004-05-07       Impact factor: 2.660

9.  Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan.

Authors:  Gianni Allais; Gennaro Bussone; Gisella Airola; Paola Borgogno; Ilaria Castagnoli Gabellari; Cristina De Lorenzo; Elena Pavia; Chiara Benedetto
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

10.  Prophylaxis of migraine.

Authors:  Ivan Garza; Jerry W Swanson
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.